We prepared a murine monoclonal antibody reactive to a human cytomegalovirus (HCMV)-induced nuclear protein with an Mr of 68000. Expression of the 68K protein was compared with the major immediate early (IE) 72K protein in various cell types after infection with HCMV or microinjection of plasmid DNA containing the major IE gene. The 68K nuclear protein was detected 2 to 3 h after appearance of the 72K protein in human embryonal lung (HEL) cells infected with HCMV. The 68K protein was distributed throughout the cytoplasm in the late phase of infection, while the 72K protein remained chiefly in the nucleus. The 68K protein was barely detected in the cells under IE conditions by immunoprecipitation, but, together with the 72K protein, it was expressed after microinjection of cloned DNA, containing only the major IE region (region 1), into the nuclei of HEL cells. The 72K protein was expressed in nuclei 2 h after microinjection, whereas the 68K protein was detected 4 to 5 h after the injection. The 68K protein was expressed after microinjection in non-permissive rodent fibroblasts or non-permissive transformed human cells in which these proteins were not expressed after viral infection.
Introduction
Human cytomegalovirus (HCMV), a herpesvirus, causes persistent and latent infections resulting in congential abnormalities in newborns (Stagno et al., 1982) and fatal pneumonitis in immunocompromised patients (Ho, 1982) . The virus has a large linear DNA genome of 240 kbp which is organized into long and short unique components that invert to give four sequence isomers (LaFemina & Hayward, 1980; Fleckenstein et al., 1982) . I-ICMV displays a strict host cell type and species specificity (Rowe et al., 1956; Smith, 1956 ), although several reports have shown that HCMV replicates to a limited degree in human epithelial ceils (MichelsonFiske et al., 1975; Knowles, 1976; Vonka et al., 1976) . Following the infection of susceptible ceils with HCMV, expression of the viral genome proceeds in three main phases: immediate early (IE), early and late (Stinski et al., 1980; DeMarchi, 1981; McDonough & Spector, 1983; Griffiths & Grundy, 1987) . Products of IE genes expressed in the absence of de novo viral protein synthesis are thought to regulate subsequent viral gene expressions in a cascade manner and to be necessary for cell type-and species-specific viral gene expression (Stinski et al., 1980; Griffiths & Grundy, 1987) . In nonpermissive cells, blocks to the progression of the lytic 0000-8938 © 1990 SGM cycle could occur at any stage between adsorption and virion production (LaFemina & Hayward, 1988) . The blocks in the steps of IE gene expression may be important for controlling the type of infection, such as permissive or non-permissive infection, and may involve cellular or nuclear factors not yet fully clarified (Hennighausen & Fleckenstein, 1986; LaFemina & Hayward, 1986) . Transcription of IE genes is restricted primarily to the region between 0.66 and 0-77 map units in the long unique sequence of the viral genome (DeMarchi, 1981; Wathen & Stinski, 1982; Stenberg et al., 1984; Stinski et al., 1983; Jahn et al., 1984) .
In the present study, we prepared a monoclonal antibody (MAb) to the 68K IE protein which was barely expressed in cells under IE conditions but was expressed by microinjection of the major IE DNA region of the virus.
Methods
Virus and cell culture. HCMV strains ADI69 (obtained from Dr Y. Nishiyama, Nagoya University School of Medicine) and Towne (from Dr Y. Watanabe, Tokai University School of Medicine) were used in this study. All virus stocks were prepared in human embryonic lung (HEL) cells and grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% foetal calf serum (FCS), penicillin (100 units/ml) and streptomycin (50 ~tg/ml). The titre of the virus stock was 5 x l06 p.f.u./ml.
MAbs. Six-week-old BALB/c mice were immunized with nuclei from HEL cells infected with HCMV strain AD169 at an m.o.i, of 5 p.f.u./cell. Nuclei were prepared 72 h after infection, sonicated for 15 s with a sonicator (Kontes) at maximum setting, and emulsified in an equal volume of Freund's complete adjuvant as described previously (Tsutsui et al., 1986) . Four weeks later, animals were injected with the same antigen in incomplete Freund's adjuvant, then injected in the same way every 2 weeks for 3 months. Three days after the final injection, spleen cells were fused to myeloma (P3-NS/1-Ag4-1) cells as described by K6hler & Milstein (1975) . Hybrid cells were obtained by growing the cells in HAT medium in 96-well tissue culture plates (Falcon). For screening and isolation of hybridoma cells, RPMI 1640 medium (Gibco) was used. Hyhridoma culture fluids were screened for reactivity with sonicated nuclei of the HCMV-infected cells, and with sonicated nuclei of uninfected cells (control), by an ELISA which was essentially the same as that of Kimura-Kuroda & Yasui (1983) . Selected cloned hyhridomas were cloned twice by the limiting dilution method. The clones were selected further for their reactivity to nuclei of HCMVinfected HEL ceils 6 h after infection, by immunofluorescence using the culture fluids.
MAb E3 against the 72K IE protein (Goldstein et aL, 1982) was a gift from Dr L. C. Goldstein (Genetic System Corporation, Seattle, Wash., U.S.A). Human serum (mk), from a child with congenital CMV infection, reactive to the major IE 72K protein in addition to late proteins was also used.
Immunoprecipitation. HEL cells plated in a 25 cm 2 flask 48 h after infection with HCMV (or uninfected cells) were labelled with psS]methionine (50 i~Ci/ml; Amersham) for 2.5 h in methionine-free DMEM supplemented with 10 % FCS or labelled with 32pi (100 p.Ci/ml, Amersham) from 24 to 48 h after infection. Radiolabelled cultures were immunoprecipitated as described by Blanton & Tevethia (1981) with our modifications (Tsutsui et al., 1986) . The immunoprecipitated samples were subjected to SDS-PAGE according to the method of Laemmli (1970) . After electrophoresis, the gels were fluorographed as described previously (Tsutsui et al., 1986) . For experiments to determine the effects of proteinase on the IE proteins, extraction buffer was added with 2 mM-PMSF, 1 lag/ml leupepsin, 1 ~tg/ml pepstatin plus 2 mM-N-ethylmaleimide (for proteinase inhibitors) and the conditions were compared with controls using extraction buffer in the absence of the proteinase inhibitors. (Thomsen & Stinski, 1981 ; Stinski et al., 1983) . The XbaI E fragment was digested with Sail and the resulting SallA fragment (Fig. 6 ) was subcloned into the plasmid vector pACYC184. The resulting plasmid, pSalA, was further digested partially with SacI and completely with Sail, and the resulting DNA fragment was subcloned into plasmid vector pUC12.
Subcloning of the
Microinjection. Cells were plated onto coverslips on which small circles had been drawn with a glass pen. Plasmid DNAs or their digested fragments were injected directly into the nuclei of cells in the circles by the glass capillary microinjection method of Graessmann & Graessmann (1976) . Samples were diluted with distilled water to a concentration of about 50 ~tg/ml and centrifuged for 5 min in an Eppendorf centrifuge before microinjection.
lmmunofluorescence. HEL ceils plated onto coverslips were infected with HCMV at an m.o.i, of 5 p.f.u./cell. For detection of IE proteins, ceils were pretreated with cycloheximide (CH; 50 ~tg/ml) for 1 h; CH was added also during and after infection for 15 h. The cells were then released from the CH-induced block in the presence of actinomycin D (100 p.g/ml) for 2 h. For detection of early proteins, HCMV-infected cells were cultured in the presence or absence of phosphonoacetic acid (PAA; 100 Ixg/ml). The H CMV-infected cells or uninfected cells were fixed in 4% paraformaldehyde in 0-1 M-phosphate buffer pH 7.4 and were then fixed in cold acetone. Fixed cells were subjected to immunofluorescence as described previously (Tsutsui et aL, 1986) . The microinjected cells in the circles on coverslips were also fixed and subjected to immunofluorescence in the same way.
Results

Isolation of hybridoma cell lines producing antibodies to HCMV-infeeted cell nuclei
Two hybridoma cell lines which produced antibodies reacting with HCMV-infected cell nuclei but not with uninfected nuclei in ELISA were selected and cloned from among more than 200 isolated colonies after three fusions. Antibodies from these two independent clones (e-3 and e-8) were identical in terms of the polypeptides with which they reacted.
An immunofluorescence study was performed on HEL cells infected with HCMV. Nuclear fluorescence was observed in HEL cells 6 h after infection with HCMV when treated with MAb e-8, and also 18 h after infection in the presence of PAA ( Fig. 1 b) as well as in the cells treated with MAb E3 (Fig. l f) . In cells infected with HCMV under IE conditions, faint nuclear fluorescence was observed in less than 30% of the cells exposed to MAb e-8 ( Fig. 1 c) , whereas nuclear fluorescence was bright in more than 80% of the cells treated with MAb E3 (Fig. lg) .
The time course of expression of the nuclear antigen of HCMV-infected HEL cells detected by MAb e-8 was compared with that of the major IE antigen detected by MAb E3. The major IE antigen appeared within 2 h after HCMV infection and was found in about 30% of cells 4 h after infection (Fig. 1 e) . No nuclear antigen was detected 4 h after infection using the MAb e-8 ( Fig. 1 a) but was observed in 40% of cells by 6 h after infection. The proportions of nuclear antigen-positive cells detected by MAb e-8 and major IE antigen-positive cells at 24 h after infection were about 60 % and 80 %, respectively. At 48 h after infection, diffuse cytoplasmic fluorescence was observed in the cells stained using MAb e-8 (Fig. ld) , whereas nuclear fluorescence was still dominant in the cells stained after treatment with MAb E3 (Fig. 1 h) .
Identification of the polypeptide recognized by MAb e-8
At 24 h after infection with HCMV strain AD169, HEL cells were labelled with [35S]methionine for 2.5 h in methionine-free medium and the cell lysates were allowed to react with MAbs e-8 and E3. Then immuno- (Fig. 2a, lane 4) , although the band was faint due to the use of ascites fluid diluted 20-fold. Polypeptides immunoprecipitated by M A b e-8 were identical whether the cells had been infected with strain AD169 or strain Towne (data not shown). H E L cells infected with H C M V were labelled with 32Pi (100 ~tCi/ml) from 24 to 48 h after infection, and then immunoprecipitation was performed using M A b s e-8 and E3. The 68K protein precipitated by M A b e-8 (Fig. 2b , lane 2) and the 72K protein precipitated by M A b E3 (Fig. 2b , lane 4) were phosphorylated. As we obtained M A b E3 in the form of ascitic fluid diluted 20-fold, it was rather difficult to get a clear band on electrophoresis gels after immunoprecipitation. Therefore we used h u m a n serum (ink) reactive to the 72K protein in IE-conditioned cells. For detection of the IE protein by immunoprecipitation, H E L cells were pretreated with CH, and C H was added also during and after H C M V infection, followed by incubation for 2 h with [35S]methionine in the presence of actinomycin D after extensive washing. In IE conditions, no detectable band was observed in the immunoprecipitate using M A b e-8 (Fig. 3, lane 1) although approximately 3 0~ faint nuclear fluorescence was detected in these conditions (Fig. 1 g) . The 72K protein was immunoprecipitated by the h u m a n serum (ink) (Fig. 3, lane 2) .
To determine whether the 68K protein is a precursor of the IE 72K protein, HCMV-infected IE-conditioned cells were labelled for 2 h after release from the C H block as described above, and then incubated in the culture medium for 2, 4 and 8 h after washing away the isotope. These cell lysates were immunoprecipitated with M A b e-8 or h u m a n serum (mk) and subjected to S D S -P A G E (Fig. 3) . The band representing the 72K protein immuno-Y. Tsutsui and T. Nogami-Satake with HCMV were labelled with 3zP i (100 ibtCi/ml ) from 24 to 48 h after infection. Immunoprecipitation was performed using MAbs e-8 and E3 as described for (a).
precipitated by the human serum (ink) was the strongest in density in the first 2 h after release from the CH block, and then gradually decreased as incubation time increased. However the size of the immunoprecipitated polypeptide did not change (Fig. 3, lanes 2, 4, 6 and 8 ).
On the other hand, no MAb e-8-specific immunoprecipitate appeared, even after a prolonged culture time after the CH block (Fig. 3, lanes 1, 3, 5 and 7) . These results suggested that the 68K protein is not a precursor of the IE 72K protein.
The 68K protein is not a degradation product of the 72K IE protein
It was possible that the 68K protein detected by MAb e-8 was a degradation product of the major IE 72K protein.
To investigate this, the following immunoprecipitation experiments were carried out. In the absence of proteinase inhibitors the HCMV-infected cell extract was incubated at 37 °C for 15, 30 or 60 min, followed by immunoprecipitation by MAb e-8 and the result was compared with the immunoprecipitated band in which the lysate, in the presence of the proteinase inhibitors, had not been incubated at 37 °C. There was no increase in terms of density of the 68K band after incubation, although bands of approximately 55K and 46K appeared in addition to the 68K band after the incubation (Fig.  4a) . IE-conditioned cells that had been labelled for 2 h with [32S]methionine after being released from the CH block were extracted in the absence of the proteinase inhibitors, incubated at 37 °C in the same manner as above and immunoprecipitated with the human serum (mk). The 72K protein did not convert to the 68K protein even after the incubation (Fig. 4b) .
Microinjection of the XbaI E fragment into HEL cell nuclei
We microinjected the cloned XbaI E fragment of HCMV into HEL cell nuclei after digestion with XbaI and extraction with phenol. Nuclear fluorescence was obtained in cells exposed to MAbs e-8, E3 or human serum (ink) around 16 h after injection. After microinjection with the XbaI E fragment, the injected cells were fixed at various times and allowed to react with either MAb e-8 or E3. Nuclear fluorescence was observed 1 h after injection in approximately 60,% of the injected cells by reacting with MAb E3 (Fig. 5 ) and also with mk serum (data not shown), whereas the nuclear fluorescence detected by MAb e-8 was observed around 5 h after the injection and the rate of expression in the injected cells was lower than that of the major IE 72K protein detected by MAb E3 (Fig. 5) .
Subcloning of the XbaI E fragment
As expression of the 68K nuclear protein detected by MAb e-8 in both HCMV-infected cells and in cells microinjected with the XbaI E fragment was different from that of the major IE 72K protein detected by MAb E3, we thought that the D N A coding region of the 68K nuclear protein would be different from that of the major IE protein (region 1). According to Stinski et al. (1983) and Thomsen et aL (1984) , the XbaI E fragment contains at least three IE regions: IE1 (region 1), IE2 (region 2) and IE3 (region 3). The major IE protein is expressed from region 1 (from 0.739 to 0.751 map units) of the XbaI E fragment. The restriction sites of this fragment digested with Sail and SacI are shown in Fig. 6 (first and second lines). The Sail A fragment was subcloned into the plasmid vector pACYC184 and the resulting clone pSalA was obtained (Fig. 6, third line) . This clone contains regions 1 and 2 but not region 3. After microinjection of pSalA DNA, the 68K nuclear protein was detected by MAb e-8. pSalA D N A was partially digested with SacI, then completely digested with SalI, resulting in a D N A fragment which contained D, E and C' but not A" of the SacI fragments; this fragment was isolated from the gel and subcloned into a plasmid vector pUC12. The clone obtained, pScDE, contained the complete IE1 region but lacked most of the IE2 region (Fig. 6 , fourth line). The electrophoretic pattern of the digested clones is shown in Fig. 6 . The pScDE clone digested with SalI was microinjected into H E L cell nuclei. In these cells, nuclear fluorescence was observed not only when treated with MAb E3 and human serum (mk) but also with MAb e-8.
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Expression of the 68K nuclear antigen and the major IE 72K antigen by microinjection with the pScDE fragment in different cells
The pScDE clone (Fig. 6 ) digested with Sail was microinjected into nuclei of different kinds of cells (Fig.  7 and Table 1 ). The 68K nuclear antigen as well as the IE 72K antigen were expressed in HeLa cells, nonpermissive transformed cells (Fig. 7 c and d) and primary cultured cells from mouse ( Fig. 7e and f) and NIH 3T3 cells, immortalized mouse cells (Fig. 7g and h) . When the percentages of nuclear fluorescence-positive cells were compared using MAbs e-8 and E3 at 6 to 8 h after injection with pScDE DNA, both the major IE 72K and 68K antigens were expressed in all the cells examined, although the rate of expression of the 72K antigen was higher than that of the 68K antigen (Table 1) .
The percentage of nuclear fluorescence-positive cells in the total infected cells was also compared after infection with HCMV strain AD169 at an m.o.i, of 5 p.f.u./cell. After infection with HCMV, the 72K antigen was expressed in the primary and immortalized cultured cells from the different species, but not in HeLa cells, although the detection level was within the limits for immunofluorescence. The 68K antigen was not detected except in HEL cells after infection with HCMV.
Discussion
We prepared a MAb to the nuclear protein of HCMVinfected cells. This 68K protein was compared with the major IE 72K protein detected by MAb E3, prepared by * Cells were fixed from 6 to 8 h after microinjection with the pScDE DNA digested with Sail. Microinjected cells in small circles on coverslips were subjected to immunofluorescence tests using either MAb e-8 or E3. Nuclear fluorescent cells were counted, for > 500 injected cells for each condition. (Stinski et al., 1983) was used as the starting material. The upper two lines show the physical map of the XbaI E insert digested with Sail or SacI. The Sail A fragment was subcloned into pACYC184. The resulting plasmid, pSallA, contains IE1 (region l) and IE2 (region 2) DNA regions according to the maps of Stinski et al. (1983) and Thomsen et al. (1984) . Then, the pSalA DNA was partially digested with SacI, and then completely digested with SalI. The resulting DNA fragment, which contains the SacI D, E and C' but not A' fragments, was isolated from the agarose gel and subcloned into plasmid vector pUCI2. Finally, pScDE which contains a complete IEI DNA region but lacks most of IEI DNA region was obtained. Goldstein et al. (1982) . Expression of the 68K protein in HEL cells detected by MAb e-8 was different from that of the major IE 72K protein in terms of the kinetics of expression of these nuclear proteins (Fig. 2) and the distribution of these proteins in HCMV-infected cells in the late phase of infection ( Fig. I d and h ). The 68K protein was barely detectable under IE conditions by immunoprecipitation, although a few cells showed faint nuclear fluorescence after their release from the CH block. This protein was expressed in the presence of PAA, an inhibitor of viral DNA synthesis. These findings appear to show that the 68K protein detected by MAb e-8 belongs to the HCMV early protein class (Stinski et al., 1980; Blanton & Tevethia, 1981) . However the 68K protein was expressed in HEL cells after microinjection with the XbaI E fragment of the HCMV genome. There are at least three coding regions for IE transcription in this DNA region between 0-660 and 0.751 map units (Stinski et al., 1983; Thomsen et al., 1984) . Stinski et al. (1983) showed that the major IE 72K protein is encoded from region 1 of the XbaI E fragment and that MAb E3 reacts with this protein.
We had thought originally that the 68K protein would be encoded from a DNA region other than region 1 encoding the major IE protein. When we subcloned the DNA region which covered region 1 only and did not include regions 2 or 3 from the XbaI E fragment of the viral genome, we were surprised to find that the 68K protein was expressed in HEL cells after microinjection with this clone, pScDE. This shows that the 68K protein detected by MAb e-8 is encoded from region l, and not from region 2 or 3.
There are three ways to interpret these results. First, the 68K protein may be a degradation product of the major IE 72K protein. We allowed partial digestion of the HCMV-infected cell extracts by removing proteinase inhibitors and compared them with the undigested products after immunoprecipitation by MAb e-8 or human serum reactive to the IE 72K protein (Fig. 4a and  b) . The results from these experiments suggested that the 68K protein is not the degradation product of the major IE 72K protein. Second, the 68K protein may derive from the major IE 72K protein after post-translational modifications, as the 68K protein was expressed following the expression of the 72K IE protein. The IE protein is subject to post-transcriptional modification (Stinski et al., 1983; Stenberg et al., 1984) . In IE conditions, and after release from the CH block, HCMV-infected cells were labelled with pSS]methionine, and then chased for different times before extraction for immunoprecipitation. The 68K protein did not appear during the course of the chase experiment (Fig. 3) . This result strongly suggests that the 68K protein is not a product of the 72K IE protein. Third, the 68K and 72K proteins may both be products, differently spliced, after primary transcription from region 1. This is feasible as Stenberg et al. (1985) showed that a series of mRNAs having different splicing patterns are transcribed from region 2.
However it remains to be explained why expression of the 68K protein is delayed with respect to that of the major IE 72K protein after infection or microinjection.
Nuclear location of the IE 72K protein was detected only 2 h after microinjection with clone pScDE containing region 1, whereas expression of the 68K protein was detected 4 to 5 h after the injection. Recently, Schickedanz et al. (1988) reported that the 89K IE protein of murine CMV (MCMV) is expressed after microinjection with a plasmid DNA containing the IE gene. In their case, up to almost 8 h following the injection of the IE DNA the 89K protein was located mainly in the cytoplasm, whereas as late as 12 h after microinjection the majority of the antigen appeared to be located in the nucleus. In our results using HCMV, both the 68K and 72K IE proteins appeared in the nucleus without a phase of cytoplasmic predominance soon after microinjection with the DNA. Nuclear location of these proteins early after the microinjection was found also in rodent fibroblasts and HeLa ceils. We are not able to explain the discrepancy between our results and those of Schickedanz et al. (1988) using MCMV. They injected the IE gene into resting NIH 3T3 cells. It is worthwhile to note that the HCMV proteins also show differences in the timing of their expression after microinjection, just as in cells after infection with HCMV.
Expression of the IE 72K protein and the 68K protein were compared in the various cell types after infection with HCMV and microinjection of the clone pScDE containing region 1 (the major IE gene). After virus infection, the IE 72K protein was expressed to various degrees even in non-permissive rodent fibroblasts, as shown previously (LaFemina & Hayward, 1988) , but not in HeLa cells, whereas the 68K protein was expressed only in the permissive HEL cells. It is noteworthy that the 68K protein is not expressed in rodent fibroblasts whereas the IE 72K protein is expressed. The reason for this may be similar to that explaining why the 68K is barely expressed under the IE condition in HEL cells, but the cause remains unknown. After microinjection with the major IE gene, both the IE 72K and 68K proteins were expressed in the non-permissive rodent fibroblasts and also in HeLa cells, which are nonpermissive transformed human cells. This agrees with the results reported by LaFemina & Hayward (1988) of cells transfected with the IE gene. Both microinjection and transfection with the IE gene are able to overcome the restriction normally preventing viral infection.
The expression rate of the 68K protein in nonpermissive cells after microinjection with the major IE gene was always lower than that of IE 72K protein.
Together with the knowledge that expression of the 68K protein after microinjection occurs 2 to 3 h after that of the IE 72K protein, it can be assumed that expression of the 72K protein appears to be necessary for that of the 68K protein even after microinjection with the major IE gene.
